Acadian Asset Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.79M | Buy |
137,902
+71,560
| +108% | +$930K | ﹤0.01% | 857 |
|
|
2025
Q1 | $701K | Buy |
+66,342
| New | +$701K | ﹤0.01% | 1003 |
|
|
2024
Q4 | – | Sell |
-10,171
| Closed | -$235K | – | 1627 |
|
|
2024
Q3 | $235K | Buy |
+10,171
| New | +$235K | ﹤0.01% | 1304 |
|
|
2023
Q3 | – | Sell |
-19,181
| Closed | -$548K | – | 1639 |
|
|
2023
Q2 | $548K | Buy |
19,181
+19,081
| +19,081% | +$545K | ﹤0.01% | 1033 |
|
|
2023
Q1 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 1707 |
|
|
2022
Q4 | – | Sell |
-75,047
| Closed | -$1.11M | – | 1766 |
|
|
2022
Q3 | $1.11M | Buy |
+75,047
| New | +$1.11M | 0.01% | 777 |
|
|
2020
Q3 | – | Sell |
-55,642
| Closed | -$2.6M | – | 2161 |
|
|
2020
Q2 | $2.6M | Buy |
55,642
+24,436
| +78% | +$1.14M | 0.01% | 663 |
|
|
2020
Q1 | $424K | Buy |
31,206
+16,219
| +108% | +$220K | ﹤0.01% | 1002 |
|
|
2019
Q4 | $163K | Buy |
+14,987
| New | +$163K | ﹤0.01% | 1333 |
|
|
2019
Q2 | – | Sell |
-5,562
| Closed | -$38K | – | 1774 |
|
|
2019
Q1 | $38K | Hold |
5,562
| – | – | ﹤0.01% | 1726 |
|
|
2018
Q4 | $25K | Buy |
5,562
+100
| +2% | +$449 | ﹤0.01% | 1530 |
|
|
2018
Q3 | $48K | Buy |
+5,462
| New | +$48K | ﹤0.01% | 1368 |
|
|
2018
Q2 | – | Sell |
-9,746
| Closed | -$54K | – | 1689 |
|
|
2018
Q1 | $54K | Buy |
+9,746
| New | +$54K | ﹤0.01% | 1339 |
|
|
2016
Q3 | – | Sell |
-1,219
| Closed | -$38K | – | 1407 |
|
|
2016
Q2 | $38K | Buy |
+1,219
| New | +$38K | ﹤0.01% | 1112 |
|
|
2014
Q1 | – | Sell |
-1,784
| Closed | -$224K | – | 956 |
|
|
2013
Q4 | $224K | Sell |
1,784
-292
| -14% | -$36.7K | ﹤0.01% | 794 |
|
|
2013
Q3 | $263K | Buy |
+2,076
| New | +$263K | ﹤0.01% | 722 |
|